Stuart O. Schweitzer, Ph.D.

Professor of Health Services UCLA School of Public Health Box 951772 Los Angeles, CA 90095-1772 (310) 825-2595 Fax: (310) 825-3317 E-mail: Sschweit@ucla.edu

Biographical Information

Stuart O. Schweitzer is Professor of Health Services. He teaches courses in health economics, health system organization and financing, pharmaceuticals, and comparative health systems. Professor Schweitzer earned his Ph.D. in economics from the University of California, Berkeley. He has taught at Wayne State University and Georgetown University, as well as having been on the research staff of The Urban Institute and the National Institutes of Health. He served on President Carter's Commission for a National Agenda for the Eighties, and has held visiting appointments at Oxford University, CREDES (Paris), ESSEC (Paris), the University of Ferrara (Italy), and the Shanghai Medical University. His research interests are in the areas of health policy, especially as they pertain to pharmaceuticals, gerontology, and the financing of health care. Dr. Schweitzer directed a 6-year assessment of health screening and promotion for the elderly, financed by the Health Care Financing Administration. He is currently directing a study of drug pricing for developing countries. He co-directs the UCLA Research Program in Pharmaceutical Economics and Policy, with Professors William Comanor and Michael Intriligator.

Selected Publications

Schweitzer SO, Pharmaceutical Economics and Policy, 2nd ed, New York: Oxford University Press, 2007.

Schweitzer SO and Comanor WS, "Pharmaceutical Prices and Expenditures," in Andersen RA, et al, (eds), Changing the U.S. Health Care System (3rd ed), San Francisco, CA: Jossey-Bass, 2006.

Di Tommaso MR and Schweitzer SO, "Why Do Biotechnology Firms Cluster? Some Possible Explanations" Chapter 8 in Sugden R, Cheng RH, and Meadows R (eds.) Urban and Regional Prosperity in a Globalized, New Economy , Cheltenham (UK): Edward Elgar Publishers, 2004.

Di Tommaso, MR, Schweitzer, S.O., "Intangible Clusters of Firms", in Bianchi P and Labory S (eds.), The Economic Importance of Intangible Assets , London: Ashgate, 2006.

Di Tommaso MR and Schweitzer SO, eds., Health Policy and High-Tech Industrial Development: Learning from Innovation in the Health Industry , Cheltenham England: Edward Elgar Publishers, 2005.

Di Tommaso and Schweitzer, "Why Apply Industrial Policy to the Health Industry?" in Di Tommaso and Schweitzer, eds., Ibid.

Schweitzer SO and Di Tommaso MR and, "The Health Industry Model: New Roles for the Health Industry", in Di Tommaso and Schweitzer, eds., Ibid.

Connell J, Schweitzer SO and, Schoenberg FP, "Factors Underlying High-Technology Industrial Clusters in the United States: The Case of Biotechnology Firms,"in Di Tommaso and Schweitzer, eds., Ibid.

Spence M, Teleki S, Schweitzer SO, and Millares, M, "The effect of direct-to-consumer pharmaceutical advertising on prescribing", Medical Care Review and Research , 62(5): 544-559, 2005.

Schweitzer SO, “Trying Times at the FDA – The Challenge of Ensuring the Safety of Imported Pharmaceuticals,” New England J of Medicine 358(17):1773-1777, April 24, 2008.